Skip to main content

ORIGINAL RESEARCH article

Front. Endocrinol., 04 March 2022
Sec. Cancer Endocrinology
Volume 13 - 2022 | https://doi.org/10.3389/fendo.2022.745327
This article is part of the Research Topic Thyroid Hormone Actions in Cancer View all 6 articles

In Vivo Clearance of Apoptotic Debris From Tumor Xenografts Exposed to Chemically Modified Tetrac: Is There a Role for Thyroid Hormone Analogues in Efferocytosis?

Retracted

A retraction of this article was approved in:

  1. Retraction: In vivo clearance of apoptotic debris from tumor xenografts exposed to chemically modified tetrac: is there a role for thyroid hormone analogues in efferocytosis?

    1. Read retraction
Kavitha GoduguKavitha Godugu1Shaker A. MousaShaker A. Mousa1Gennadi V. GlinskyGennadi V. Glinsky2Hung-Yun Lin,,Hung-Yun Lin3,4,5Paul J. Davis,*Paul J. Davis1,6*
  • 1Pharmaceutical Research Institute, Albany College of Pharmacy and Health Sciences, Rensselaer, NY, United States
  • 2Institute of Engineering in Medicine, University of California, San Diego, CA, United States
  • 3Ph.D. Program for Cancer Molecular Biology and Drug Discovery, College of Medical Science and Technology, Taipei Medical University, Taipei, Taiwan
  • 4Cancer Center, Wan Fang Hospital, Taipei Medical University, Taipei, Taiwan
  • 5Traditional Herbal Medicine Research Center of Taipei Medical University Hospital, Taipei Medical University, Taipei, Taiwan
  • 6Department of Medicine, Albany Medical College, Albany, NY, United States

This article has been retracted. Please follow the link to the full retraction notice for details.

Citation: Godugu K, Mousa SA, Glinsky GV, Lin H-Y and Davis PJ (2022) In Vivo Clearance of Apoptotic Debris From Tumor Xenografts Exposed to Chemically Modified Tetrac: Is There a Role for Thyroid Hormone Analogues in Efferocytosis? Front. Endocrinol. 13:745327. doi: 10.3389/fendo.2022.745327

Received: 16 September 2021; Accepted: 28 January 2022;
Published: 04 March 2022; Retracted: 21 August 2024.

Edited by:

Maria Del Mar Montesinos, CONICET Centre for Research in Clinical Biochemistry and Immunology (CIBICI), Argentina

Reviewed by:

Maria Celeste Diaz Flaqué, CONICET Institute for Biomedical Research (BIOMED), Argentina
Cinthia Rosemblit, CONICET Institute for Biomedical Research (BIOMED), Argentina

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.